Acetaminophen 325 MG butalbital 50 MG Caffeine 40 MG Oral Tablet

INDICATIONS AND USAGE Butalbital, acetaminophen, and caffeine tablets, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.

Lannett Company, Inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] dyspnoea` `[4] nausea` `[5] diarrhoea` `[6] pain` `[7] dizziness` `[8] headache` `[9] off label use` `[10] asthenia`

1 year ago

ROUND BLUE LCI 1695

1 year ago

LCI 1695 ROUND BLUE

HOW SUPPLIED

BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE Tablets, USP contain 50 mg butalbital, 325 mg acetaminophen, and 40 mg caffeine.

BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE Tablets USP, 50 mg/325mg/40 mg are light-blue, speckled, round uncoated tablets, debossed "1695" on one side and "LCI" on the other side and are supplied in bottles of 100 (NDC 0527-1695-01) and bottles of 500 (NDC 0527-1695-05). Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP, with a child-resistant closure (as required). Distributed by: Lannett Company, Inc. Philadelphia, PA 19136 CIB70307C Rev. 07/20

More pills like ROUND LCI 1695

Related Pills

Butalbital Acetaminophen and Caffeine Acetaminophen 325 MG butalbital 50 MG Caffeine 40 MG Oral Tablet

Lannett Company, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site